Vai trò của phẫu thuật xâm lấn tối thiểu trong quản lý ung thư biểu mô ống tụy khu trú: một đánh giá

Rasha T. Kakati1, Samer Naffouje2, Philip M. Spanheimer1, Fadi S. Dahdaleh3
1Department of Surgical Oncology, University of North Carolina, Chapel Hill, USA
2Department of Surgical Oncology, Cleveland Clinic Foundation, Cleveland, USA
3Department of Surgical Oncology, Edward-Elmhurst Health, Naperville, USA

Tóm tắt

Ung thư biểu mô ống tụy (PDAC) vẫn là một dạng ung thư có mức độ nguy hiểm cao với đa số bệnh nhân không đủ điều kiện để can thiệp phẫu thuật với mục đích chữa bệnh. Các phẫu thuật cắt bỏ tụy là những ca phẫu thuật đòi hỏi kỹ thuật cao, kèm theo tỷ lệ biến chứng và tử vong đáng kể. Các phẫu thuật cắt bỏ tụy xâm lấn tối thiểu (MIPRs), bao gồm các phương pháp mổ nội soi và mổ robot, có thể cải thiện kết quả hậu phẫu bằng cách giảm thiểu tác động sinh lý của phẫu thuật mở. Số lượng thử nghiệm ngẫu nhiên có đối chứng còn hạn chế cũng như nhiều báo cáo hồi cứu đã tập trung vào kết quả của MIPR và vai trò của chúng trong việc quản lý nhiều loại khối u, bao gồm cả PDAC. Hiện nay, MIPRs thường được coi là những lựa chọn thay thế chấp nhận được so với phẫu thuật mở khi có xu hướng cải thiện các chỉ số ngắn hạn được quan sát thấy. Tuy nhiên, vẫn còn một số câu hỏi liên quan đến tính đủ về oncologic của MIPR do kinh nghiệm lâu dài còn kém hơn so với các kỹ thuật phẫu thuật mở. Bài đánh giá này nhằm tóm tắt các bằng chứng hiện có về MIPRs với trọng tâm là PDAC.

Từ khóa

#ung thư tụy #phẫu thuật xâm lấn tối thiểu #ung thư biểu mô ống tụy #cắt bỏ tụy #kết quả phẫu thuật

Tài liệu tham khảo

Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H, Dervenis C, Bassi C, Buchler MW, Neoptolemos JP, Pancreatic Cancer Meta-Analysis G (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143(1):75–83. https://doi.org/10.1001/archsurg.2007.17 Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30. https://doi.org/10.3322/caac.21590 Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Chone L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O’Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB, Canadian Cancer Trials G, the Unicancer GIPG (2018) FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med 379(25):2395–2406. https://doi.org/10.1056/NEJMoa1809775 Schwarz JL, Hogg ME (2021) Current state of minimally invasive pancreatic surgery. J Surg Oncol 123(6):1370. https://doi.org/10.1002/jso.26412 Zhang M, Fang R, Mou Y, Chen R, Xu X, Zhang R, Yan J, Jin W, Ajoodhea H (2015) LDP vs ODP for pancreatic adenocarcinoma: a case matched study from a single-institution. BMC Gastroenterol. https://doi.org/10.1186/s12876-015-0411-2 Sanchez-Velazquez P, Muller X, Malleo G, Park JS, Hwang HK, Napoli N, Javed AA, Inoue Y, Beghdadi N, Kalisvaart M, Vigia E, Walsh CD, Lovasik B, Busquets J, Scandavini C, Robin F, Yoshitomi H, Mackay TM, Busch OR, Hartog H, Heinrich S, Gleisner A, Perinel J, Passeri M, Lluis N, Raptis DA, Tschuor C, Oberkofler CE, DeOliveira ML, Petrowsky H, Martinie J, Asbun H, Adham M, Schulick R, Lang H, Koerkamp BG, Besselink MG, Han HS, Miyazaki M, Ferrone CR, Fernandez-Del Castillo C, Lillemoe KD, Sulpice L, Boudjema K, Del Chiaro M, Fabregat J, Kooby DA, Allen P, Lavu H, Yeo CJ, Barroso E, Roberts K, Muiesan P, Sauvanet A, Saiura A, Wolfgang CL, Cameron JL, Boggi U, Yoon DS, Bassi C, Puhan MA, Clavien PA (2019) Benchmarks in pancreatic surgery: a novel tool for unbiased outcome comparisons. Ann Surg 270(2):211–218. https://doi.org/10.1097/SLA.0000000000003223 van Hilst J, de Graaf N, Abu Hilal M, Besselink MG (2021) The landmark series: minimally invasive pancreatic resection. Ann Surg Oncol 28(3):1447. https://doi.org/10.1245/s10434-020-09335-3 Poves I, Burdio F, Morato O, Iglesias M, Radosevic A, Ilzarbe L, Visa L, Grande L (2018) Comparison of perioperative outcomes between laparoscopic and open approach for pancreatoduodenectomy: the PADULAP randomized controlled trial. Ann Surg 268(5):731–739. https://doi.org/10.1097/SLA.0000000000002893 de Rooij T, van Hilst J, Bosscha K, Dijkgraaf MG, Gerhards MF, Groot Koerkamp B, Hagendoorn J, de Hingh IH, Karsten TM, Lips DJ, Luyer MD, Molenaar IQ, van Santvoort HC, Tran TCK, Busch OR, Festen S, Besselink MG, Dutch Pancreatic Cancer G (2018) Minimally invasive versus open pancreatoduodenectomy (LEOPARD-2): study protocol for a randomized controlled trial. Trials 19(1):1. https://doi.org/10.1186/s13063-017-2423-4 Chalikonda S, Aguilar-Saavedra JR, Walsh RM (2012) Laparoscopic robotic-assisted pancreaticoduodenectomy: a case-matched comparison with open resection. Surg Endosc 26(9):2397. https://doi.org/10.1007/s00464-012-2207-6 Jin J, Shi Y, Chen M, Qian J, Qin K, Wang Z, Chen W, Jin W, Lu F, Li Z, Wu Z, Jian L, Han B, Liang X, Sun C, Mou Y, Yin X, Huang H, Chen H, Gemenetzis G, Deng X, Peng C, Shen B (2021) Robotic versus open pancreatoduodenectomy for pancreatic and periampullary tumors (PORTAL): a study protocol for a multicenter phase III non-inferiority randomized controlled trial. Trials 22(1):954. https://doi.org/10.1186/s13063-021-05939-6 Van Hilst J, de Rooij T, Bosscha K, Brinkman DJ, Van Dieren S, Dijkgraaf MG, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ, Luyer MD, Busch OR, Festen S, Besselink MG (2019) Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial. Lancet Gastroenterol Hepatol 4:199 Khachfe HH, Nassour I, Hammad AY, Hodges JC, AlMasri S, Liu H, deSilva A, Kraftician J, Lee KK, Pitt HA, Zureikat AH, Paniccia A (2022) Robotic pancreaticoduodenectomy: increased adoption and improved outcomes - is laparoscopy still justified? Ann Surg. https://doi.org/10.1097/SLA.0000000000005687 Nassour I, Wang SC, Christie A, Augustine MM, Porembka MR, Yopp AC, Choti MA, Mansour JC, Xie XJ, Polanco PM, Minter RM (2018) Minimally invasive versus open pancreaticoduodenectomy: a propensity-matched study from a national cohort of patients. Ann Surg 268(1):151–157. https://doi.org/10.1097/SLA.0000000000002259 Emmen A, Gorgec B, Zwart MJW, Daams F, Erdmann J, Festen S, Gouma DJ, van Gulik TM, van Hilst J, Kazemier G, Lof S, Sussenbach SI, Tanis PJ, Zonderhuis BM, Busch OR, Swijnenburg RJ, Besselink MG, for HPBA (2022) Impact of shifting from laparoscopic to robotic surgery during 600 minimally invasive pancreatic and liver resections. Surg Endosc. https://doi.org/10.1007/s00464-022-09735-4 Garland ME, Gonzalez JE, Polanco Santana JC, Kent TS (2022) Current trends in pancreatoduodenectomy: a NSQIP study. J Am Coll Surg 235(5):S48. https://doi.org/10.1097/01.XCS.0000896068.79597.a0 Gagner M, Pomp A (1994) Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 8(5):408–410. https://doi.org/10.1007/BF00642443 Wang M, Li D, Chen R, Huang X, Li J, Liu Y, Liu J, Cheng W, Chen X, Zhao W, Li J, Tan Z, Huang H, Li D, Zhu F, Qin T, Ma J, Yu G, Zhou B, Zheng S, Tang Y, Han W, Meng L, Ke J, Feng F, Chen B, Yin X, Chen W, Ma H, Xu J, Liu Y, Lin R, Dong Y, Yu Y, Liu J, Zhang H, Qin R, Minimally Invasive Treatment Group in the Pancreatic Disease Branch of China’s International E, Promotion Association for M, Healthcare (2021) Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol 6(6):438–447. https://doi.org/10.1016/S2468-1253(21)00054-6 Feng Q, Liao W, Xin Z, Jin H, Du J, Cai Y, Liao M, Yuan K, Zeng Y (2021) Laparoscopic pancreaticoduodenectomy versus conventional open approach for patients with pancreatic duct adenocarcinoma: an up-to-date systematic review and meta-analysis. Front Oncol 11:749140. https://doi.org/10.3389/fonc.2021.749140 Feng Q, Liao W, Xin Z, Jin H, Du J, Cai Y, Liao M, Yuan K, Zeng Y (2021) Laparoscopic pancreaticoduodenectomy. Front Oncol 11:749140. https://doi.org/10.3389/fonc.2021.749140 Kantor O, Talamonti MS, Sharpe S, Lutfi W, Winchester DJ, Roggin KK, Bentrem DJ, Prinz RA, Baker MS (2017) Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg 213(3):512–515. https://doi.org/10.1016/j.amjsurg.2016.10.030 Croome KP, Farnell MB, Que FG, Reid-Lombardo KM, Truty MJ, Nagorney DM, Kendrick ML (2014) Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches? Ann Surg 260(4):633–638. https://doi.org/10.1097/SLA.0000000000000937 Naffouje SA, Kamarajah SK, Denbo JW, Salti GI, Dahdaleh FS (2022) surgical approach does not affect return to intended oncologic therapy following pancreaticoduodenectomy for pancreatic adenocarcinoma: a propensity-matched study. Ann Surg Oncol 29(12):7793–7803. https://doi.org/10.1245/s10434-022-12347-w Magge D, Zeh HJ, Hogg ME (2018) Laparoscopic and robotic resection for pancreatic cancer. In: Beger HG, Warshaw AL, Hruban RH, Büchler MW, Lerch MM, Neoptolemos JP et al (eds) The pancreas. John Wiley & Sons Ltd, Chichester, UK, p 804 Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A (2019) Comparing short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high volume centers. Ann Surg 270(6):1147–1155. https://doi.org/10.1097/SLA.0000000000002810 Eguia E, Kuo PC, Sweigert PJ, Nelson MH, Aranha GV, Abood G, Godellas C, Baker MS (2019) The laparoscopic approach to pancreatoduodenectomy is cost neutral in very high-volume centers. Surgery 166(6):1027–1032. https://doi.org/10.1016/j.surg.2019.07.004 Hoehn RS, Nassour I, Adam MA, Winters S, Paniccia A, Zureikat AH (2021) National trends in robotic pancreas surgery. J Gastrointest Surg 25(4):983–990. https://doi.org/10.1007/s11605-020-04591-w de Rooij T, van Hilst J, Boerma D, Bonsing BA, Daams F, van Dam RM, Dijkgraaf MG, van Eijck CH, Festen S, Gerhards MF, Koerkamp BG, van der Harst E, de Hingh IH, Kazemier G, Klaase J, de Kleine RH, van Laarhoven CJ, Lips DJ, Luyer MD, Molenaar IQ, Patijn GA, Roos D, Scheepers JJ, van der Schelling GP, Steenvoorde P, Vriens MR, Wijsman JH, Gouma DJ, Busch OR, Hilal MA, Besselink MG, Dutch Pancreatic Cancer G (2016) Impact of a nationwide training program in minimally invasive distal pancreatectomy (LAELAPS). Ann Surg 264(5):754–762. https://doi.org/10.1097/SLA.0000000000001888 Hogg ME, Besselink MG, Clavien PA, Fingerhut A, Jeyarajah DR, Kooby DA, Moser AJ, Pitt HA, Varban OA, Vollmer CM, Zeh HJ, Hansen P, Minimally Invasive Pancreatic Resection Organizing C (2017) Training in minimally invasive pancreatic resections: a paradigm shift away from “See one, Do one, Teach one.” HPB Oxford) 19(3):234–245. https://doi.org/10.1016/j.hpb.2017.01.016 de Rooij T, van Hilst J, Topal B, Bosscha K, Brinkman DJ, Gerhards MF, de Hingh IH, Karsten TM, Lips DJ, Luyer MD, Marsman HA, van Rijssen LB, Steen MW, Busch OR, Festen S, Besselink MG, Dutch Pancreatic Cancer G (2019) Outcomes of a multicenter training program in laparoscopic pancreatoduodenectomy (LAELAPS-2). Ann Surg 269(2):344–350. https://doi.org/10.1097/SLA.0000000000002563 Ramirez Barriga M, Rojas A, Roggin KK, Talamonti MS, Hogg ME (2022) Development of a two-week dedicated robotic surgery curriculum for general surgery residents. J Surg Educ 79(4):861–866. https://doi.org/10.1016/j.jsurg.2022.02.015 Schmidt CR, Harris BR, Musgrove KA, Rao P, Marsh JW, Thomay AA, Hogg ME, Zeh HJ, Zureikat AH, Boone BA (2021) Formal robotic training diminishes the learning curve for robotic pancreatoduodenectomy: implications for new programs in complex robotic surgery. J Surg Oncol 123(2):375–380. https://doi.org/10.1002/jso.26284 Kornaropoulos M, Moris D, Beal EW, Makris MC, Mitrousias A, Petrou A, Felekouras E, Michalinos A, Vailas M, Schizas D, Papalampros A (2017) Total robotic pancreaticoduodenectomy: a systematic review of the literature. Surg Endosc 31(11):4382–4392. https://doi.org/10.1007/s00464-017-5523-z Williams MD, Bhama AR, Naffouje S, Kamarajah SK, Becerra AZ, Zhang Y, Pappas SG, Dahdaleh FS (2022) Effect of operative time on outcomes of minimally invasive versus open pancreatoduodenectomy. J Gastrointest Surg. https://doi.org/10.1007/s11605-022-05504-9 Nassour I, Choti MA, Porembka MR, Yopp AC, Wang SC, Polanco PM (2018) Robotic-assisted versus laparoscopic pancreaticoduodenectomy: oncological outcomes. Surg Endosc 32(6):2907–2913. https://doi.org/10.1007/s00464-017-6002-2 Boone BA, Zenati M, Hogg ME, Steve J, Moser AJ, Bartlett DL, Zeh HJ, Zureikat AH (2015) Assessment of quality outcomes for robotic pancreaticoduodenectomy: identification of the learning curve. JAMA Surg 150(5):416–422. https://doi.org/10.1001/jamasurg.2015.17 Zureikat AH, Postlewait LM, Liu Y, Gillespie TW, Weber SM, Abbott DE, Ahmad SA, Maithel SK, Hogg ME, Zenati M, Cho CS, Salem A, Xia B, Steve J, Nguyen TK, Keshava HB, Chalikonda S, Walsh RM, Talamonti MS, Stocker SJ, Bentrem DJ, Lumpkin S, Kim HJ, Zeh HJ 3rd, Kooby DA (2016) A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy. Ann Surg 264(4):640–649. https://doi.org/10.1097/SLA.0000000000001869 Vining CC, Kuchta K, Berger Y, Paterakos P, Schuitevoerder D, Roggin KK, Talamonti MS, Hogg ME (2021) Robotic pancreaticoduodenectomy decreases the risk of clinically relevant post-operative pancreatic fistula: a propensity score matched NSQIP analysis. HPB (Oxford) 23(3):367–378. https://doi.org/10.1016/j.hpb.2020.07.004 Fu Y, Qiu J, Yu Y, Wu D, Zhang T (2022) Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients. Front Surg 9:989065. https://doi.org/10.3389/fsurg.2022.989065 Cai J, Ramanathan R, Zenati MS, Al Abbas A, Hogg ME, Zeh HJ, Zureikat AH (2020) Robotic pancreaticoduodenectomy is associated with decreased clinically relevant pancreatic fistulas: a propensity-matched analysis. J Gastrointest Surg 24(5):1111–1118. https://doi.org/10.1007/s11605-019-04274-1 van Oosten AF, Ding D, Habib JR, Irfan A, Schmocker RK, Sereni E, Kinny-Koster B, Wright M, Groot VP, Molenaar IQ, Cameron JL, Makary M, Burkhart RA, Burns WR, Wolfgang CL, He J (2021) Perioperative outcomes of robotic pancreaticoduodenectomy: a propensity-matched analysis to open and laparoscopic pancreaticoduodenectomy. J Gastrointest Surg 25(7):1795–1804. https://doi.org/10.1007/s11605-020-04869-z Jung JP, Zenati MS, Dhir M, Zureikat AH, Zeh HJ, Simmons RL, Hogg ME (2018) Use of video review to investigate technical factors that may be associated with delayed gastric emptying after pancreaticoduodenectomy. JAMA Surg 153(10):918–927. https://doi.org/10.1001/jamasurg.2018.2089 Nassour I, Winters SB, Hoehn R, Tohme S, Adam MA, Bartlett DL, Lee KK, Paniccia A, Zureikat AH (2020) Long-term oncologic outcomes of robotic and open pancreatectomy in a national cohort of pancreatic adenocarcinoma. J Surg Oncol 122(2):234–242. https://doi.org/10.1002/jso.25958 Kauffmann EF, Napoli N, Menonna F, Iacopi S, Lombardo C, Bernardini J, Amorese G, Cacciato Insilla A, Funel N, Campani D, Cappelli C, Caramella D, Boggi U (2019) A propensity score-matched analysis of robotic versus open pancreatoduodenectomy for pancreatic cancer based on margin status. Surg Endosc 33(1):234–242. https://doi.org/10.1007/s00464-018-6301-2 Weng Y, Jiang Y, Fu N, Jin J, Shi Y, Huo Z, Deng X, Peng C, Shen B (2021) Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis. Surg Endosc 35(7):3437–3448. https://doi.org/10.1007/s00464-020-07791-2 Girgis MD, Zenati MS, King JC, Hamad A, Zureikat AH, Zeh HJ, Hogg ME (2021) Oncologic outcomes after robotic pancreatic resections are not inferior to open surgery. Ann Surg 274(3):e262–e268. https://doi.org/10.1097/SLA.0000000000003615 Baimas-George M, Watson M, Murphy KJ, Iannitti D, Baker E, Ocuin L, Vrochides D, Martinie JB (2020) Robotic pancreaticoduodenectomy may offer improved oncologic outcomes over open surgery: a propensity-matched single-institution study. Surg Endosc 34(8):3644–3649. https://doi.org/10.1007/s00464-020-07564-x ClinicalTrials.gov. Observation of perioperative outcomes of robotic pancreaticoduodenectomy. Observation of perioperative outcomes of robotic pancreaticoduodenectomy - Full Text View - ClinicalTrials.gov. Rosemurgy A, Ross S, Bourdeau T, Jacob K, Thomas J, Przetocki V, Luberice K, Sucandy I (2021) Cost analysis of pancreaticoduodenectomy at a high-volume robotic hepatopancreaticobiliary surgery program. J Am Coll Surg 232(4):461–469. https://doi.org/10.1016/j.jamcollsurg.2020.12.062 Williams MD, Bhama AR, Naffouje S, Kamarajah SK, Becerra AZ, Zhang Y, Pappas SG, Dahdaleh FS (2023) Effect of operative time on outcomes of minimally invasive versus open pancreatoduodenectomy. J Gastrointest Surg 27(1):93–104. https://doi.org/10.1007/s11605-022-05504-9 Vining CC, Kuchta K, Schuitevoerder D, Paterakos P, Berger Y, Roggin KK, Talamonti MS, Hogg ME (2020) Risk factors for complications in patients undergoing pancreaticoduodenectomy: a NSQIP analysis with propensity score matching. J Surg Oncol 122(2):183. https://doi.org/10.1002/jso.25942 Brennan MF, Moccia RD, Klimstra D (1996) Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 223(5):506–511. https://doi.org/10.1097/00000658-199605000-00006 Soreide K, Olsen F, Nymo LS, Kleive D, Lassen K (2019) A nationwide cohort study of resection rates and short-term outcomes in open and laparoscopic distal pancreatectomy. HPB (Oxford) 21(6):669–678. https://doi.org/10.1016/j.hpb.2018.10.006 de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal M, Busch O, Besselink M, Dutch Pancreatic Cancer G (2019) Minimally invasive versus open distal pancreatectomy (LEOPARD): a multicenter patient-blinded randomized controlled trial. Ann Surg 269(1):2–9. https://doi.org/10.1097/SLA.0000000000002979 Ricci C, Casadei R, Taffurelli G, Toscano F, Pacilio CA, Bogoni S, D’Ambra M, Pagano N, Di Marco MC, Minni F (2015) Laparoscopic versus open distal pancreatectomy for ductal adenocarcinoma: a systematic review and meta-analysis. J Gastrointest Surg 19(4):770–781. https://doi.org/10.1007/s11605-014-2721-z van Hilst J, de Rooij T, Klompmaker S, Rawashdeh M, Aleotti F, Al-Sarireh B, Alseidi A, Ateeb Z, Balzano G, Berrevoet F, Bjornsson B, Boggi U, Busch OR, Butturini G, Casadei R, Del Chiaro M, Chikhladze S, Cipriani F, van Dam R, Damoli I, van Dieren S, Dokmak S, Edwin B, van Eijck C, Fabre JM, Falconi M, Farges O, Fernandez-Cruz L, Forgione A, Frigerio I, Fuks D, Gavazzi F, Gayet B, Giardino A, Groot Koerkamp B, Hackert T, Hassenpflug M, Kabir I, Keck T, Khatkov I, Kusar M, Lombardo C, Marchegiani G, Marshall R, Menon KV, Montorsi M, Orville M, de Pastena M, Pietrabissa A, Poves I, Primrose J, Pugliese R, Ricci C, Roberts K, Rosok B, Sahakyan MA, Sanchez-Cabus S, Sandstrom P, Scovel L, Solaini L, Soonawalla Z, Souche FR, Sutcliffe RP, Tiberio GA, Tomazic A, Troisi R, Wellner U, White S, Wittel UA, Zerbi A, Bassi C, Besselink MG, Abu Hilal M, European Consortium on Minimally Invasive Pancreatic S (2019) Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): a pan-european propensity score matched study. Ann Surg 269(1):10–17. https://doi.org/10.1097/SLA.0000000000002561 Asbun HJ, Moekotte AL, Vissers FL, Kunzler F, Cipriani F, Alseidi A, D’Angelica MI, Balduzzi A, Bassi C, Bjornsson B, Boggi U, Callery MP, Del Chiaro M, Coimbra FJ, Conrad C, Cook A, Coppola A, Dervenis C, Dokmak S, Edil BH, Edwin B, Giulianotti PC, Han HS, Hansen PD, van der Heijde N, van Hilst J, Hester CA, Hogg ME, Jarufe N, Jeyarajah DR, Keck T, Kim SC, Khatkov IE, Kokudo N, Kooby DA, Korrel M, de Leon FJ, Lluis N, Lof S, Machado MA, Demartines N, Martinie JB, Merchant NB, Molenaar IQ, Moravek C, Mou YP, Nakamura M, Nealon WH, Palanivelu C, Pessaux P, Pitt HA, Polanco PM, Primrose JN, Rawashdeh A, Sanford DE, Senthilnathan P, Shrikhande SV, Stauffer JA, Takaori K, Talamonti MS, Tang CN, Vollmer CM, Wakabayashi G, Walsh RM, Wang SE, Zinner MJ, Wolfgang CL, Zureikat AH, Zwart MJ, Conlon KC, Kendrick ML, Zeh HJ, Hilal MA, Besselink MG (2020) The Miami international evidence-based guidelines on minimally invasive pancreas resection. Ann Surg 271(1):1–14. https://doi.org/10.1097/SLA.0000000000003590 Cuschieri A (1994) Laparoscopic surgery of the pancreas. J R Coll Surg Edinb 39(3):178–184 Venkat R, Edil BH, Schulick RD, Lidor AO, Makary MA, Wolfgang CL (2012) Laparoscopic distal pancreatectomy is associated with significantly less overall morbidity compared to the open technique: a systematic review and meta-analysis. Ann Surg 255(6):1048–1059. https://doi.org/10.1097/SLA.0b013e318251ee09 Bjornsson B, Larsson AL, Hjalmarsson C, Gasslander T, Sandstrom P (2020) Comparison of the duration of hospital stay after laparoscopic or open distal pancreatectomy: randomized controlled trial. Br J Surg 107(10):1281–1288. https://doi.org/10.1002/bjs.11554 Korrel M, Vissers FL, van Hilst J, de Rooij T, Dijkgraaf MG, Festen S, Groot Koerkamp B, Busch OR, Luyer MD, Sandstrom P, Abu Hilal M, Besselink MG, Bjornsson B, International Minimally Invasive Pancreatic Resection Trialists G (2021) Minimally invasive versus open distal pancreatectomy: an individual patient data meta-analysis of two randomized controlled trials. HPB (Oxford) 23(3):323–330. https://doi.org/10.1016/j.hpb.2020.10.022 Riviere D, Gurusamy KS, Kooby DA, Vollmer CM, Besselink MG, Davidson BR, van Laarhoven CJ (2016) Laparoscopic versus open distal pancreatectomy for pancreatic cancer. Cochrane Database Syst Rev 4(4):CD011391. https://doi.org/10.1002/14651858.CD011391.pub2 Maggino L, Liu JB, Ecker BL, Pitt HA, Vollmer CM Jr (2018) Impact of operative time on outcomes after pancreatic resection: a risk-adjusted analysis using the american college of surgeons NSQIP database. J Am Coll Surg 226(5):844–857. https://doi.org/10.1016/j.jamcollsurg.2018.01.004 de Rooij T, Besselink MG, Shamali A, Butturini G, Busch OR, Edwin B, Troisi R, Fernandez-Cruz L, Dagher I, Bassi C, Abu HM, group Dt (2016) Pan-European survey on the implementation of minimally invasive pancreatic surgery with emphasis on cancer. HPB (Oxford) 18(2):170–176. https://doi.org/10.1016/j.hpb.2015.08.005 Chen K, Pan Y, Huang CJ, Chen QL, Zhang RC, Zhang MZ, Wang GY, Wang XF, Mou YP, Yan JF (2021) Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy. BMC Cancer 21(1):382. https://doi.org/10.1186/s12885-021-08117-8 Kooby DA, Hawkins WG, Schmidt MC, Weber SM, Bentrem DJ, Gillespie TW, Sellers JB, Merchant NB, Scoggins CR, Martin RCG, Kim HJ, Ahmad S, Cho CS, Parikh AA, Chu CK, Hamilton NA, Doyle CJ, Pinchot S, Hayman A, McClaine R, Nakeeb A, Staley CA, McMasters KM, Lillemoe KD (2010) A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate? J Am Coll Surg 210(5):779. https://doi.org/10.1016/j.jamcollsurg.2009.12.033 Nassour I, Wang SC, Porembka MR, Augustine MM, Yopp AC, Mansour JC, Minter RM, Choti MA, Polanco PM (2017) Conversion of minimally invasive distal pancreatectomy: predictors and outcomes. Ann Surg Oncol 24(12):3725–3731. https://doi.org/10.1245/s10434-017-6062-5 Abu Hilal M, Hamdan M, Di Fabio F, Pearce NW, Johnson CD (2012) Laparoscopic versus open distal pancreatectomy: a clinical and cost-effectiveness study. Surg Endosc 26(6):1670–1674. https://doi.org/10.1007/s00464-011-2090-6 Xourafas D, Ashley SW, Clancy TE (2017) Comparison of perioperative outcomes between open, laparoscopic, and robotic distal pancreatectomy: an analysis of 1815 patients from the ACS-NSQIP procedure-targeted pancreatectomy database. J Gastrointest Surg 21(9):1442–1452. https://doi.org/10.1007/s11605-017-3463-5 Li P, Zhang H, Chen L, Liu T, Dai M (2023) Robotic versus laparoscopic distal pancreatectomy on perioperative outcomes: a systematic review and meta-analysis. Updates Surg 75(1):7–21. https://doi.org/10.1007/s13304-022-01413-3 Shakir M, Boone BA, Polanco PM, Zenati MS, Hogg ME, Tsung A, Choudry HA, Moser AJ, Bartlett DL, Zeh HJ, Zureikat AH (2015) The learning curve for robotic distal pancreatectomy: an analysis of outcomes of the first 100 consecutive cases at a high-volume pancreatic centre. HPB (Oxford) 17(7):580–586. https://doi.org/10.1111/hpb.12412 Zhao W, Liu C, Li S, Geng D, Feng Y, Sun M (2018) Safety and efficacy for robot-assisted versus open pancreaticoduodenectomy and distal pancreatectomy: a systematic review and meta-analysis. Surg Oncol 27(3):468–478. https://doi.org/10.1016/j.suronc.2018.06.001 van Hilst J, Korrel M, de Rooij T, Lof S, Busch OR, Groot Koerkamp B, Kooby DA, van Dieren S, Abu Hilal M, Besselink MG, group Ds (2019) Oncologic outcomes of minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol 45(5):719–727. https://doi.org/10.1016/j.ejso.2018.12.003 Chopra A, Nassour I, Zureikat A, Paniccia A (2021) Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma. Updates Surg 73(3):947–953. https://doi.org/10.1007/s13304-020-00927-y Nakata K, Nakamura M (2021) The current status and future directions of robotic pancreatectomy. Ann Gastroenterol Surg 5(4):467–476. https://doi.org/10.1002/ags3.12446 Niu X, Yu B, Yao L, Tian J, Guo T, Ma S, Cai H (2019) Comparison of surgical outcomes of robot-assisted laparoscopic distal pancreatectomy versus laparoscopic and open resections: a systematic review and meta-analysis. Asian J Surg 42(1):32–45. https://doi.org/10.1016/j.asjsur.2018.08.011 Huang B, Feng L, Zhao J (2016) Systematic review and meta-analysis of robotic versus laparoscopic distal pancreatectomy for benign and malignant pancreatic lesions. Surg Endosc 30(9):4078–4085. https://doi.org/10.1007/s00464-015-4723-7 Stafford AT, Walsh RM (2015) Robotic surgery of the pancreas: the current state of the art. J Surg Oncol 112(3):289–294. https://doi.org/10.1002/jso.23952 Liu R, Liu Q, Zhao ZM, Tan XL, Gao YX, Zhao GD (2017) Robotic versus laparoscopic distal pancreatectomy: a propensity score-matched study. J Surg Oncol 116(4):461–469. https://doi.org/10.1002/jso.24676 Lee SY, Allen PJ, Sadot E, D’Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR, Kingham TP (2015) Distal pancreatectomy: a single institution’s experience in open, laparoscopic, and robotic approaches. J Am Coll Surg 220(1):18–27. https://doi.org/10.1016/j.jamcollsurg.2014.10.004 Zhou JY, Xin C, Mou YP, Xu XW, Zhang MZ, Zhou YC, Lu C, Chen RG (2016) Robotic versus laparoscopic distal pancreatectomy: a meta-analysis of short-term outcomes. PLoS ONE 11(3):e0151189. https://doi.org/10.1371/journal.pone.0151189 Boggi U, Amorese G, Vistoli F, Caniglia F, De Lio N, Perrone V, Barbarello L, Belluomini M, Signori S, Mosca F (2015) Laparoscopic pancreaticoduodenectomy: a systematic literature review. Surg Endosc 29(1):9. https://doi.org/10.1007/s00464-014-3670-z Wang X, Li Y, Cai Y, Liu X, Peng B (2017) Laparoscopic total pancreatectomy: case report and literature review. Medicine (Baltimore) 96(3):e5869. https://doi.org/10.1097/MD.0000000000005869 Scholten L, Klompmaker S, Van Hilst J, Annecchiarico MM, Balzano G, Casadei R, Fabre JM, Falconi M, Ferrari G, Kerem M, Khatkov IE, Lombardo C, Manzoni A, Mazzola M, Napoli N, Rosso EE, Tyutyunnik P, Wellner UF, Fuks D, Burdio F, Keck T, Hilal MA, Besselink MG, Boggi U (2023) Outcomes after minimally invasive versus open total pancreatectomy: a pan-european propensity score matched study. Ann Surg 277(2):313–320. https://doi.org/10.1097/SLA.0000000000005075 Cai Y, Gao P, Peng B (2020) A novel surgical approach for en-bloc resection laparoscopic total pancreatectomy. Medicine (Baltimore) 99(28):e20948. https://doi.org/10.1097/MD.0000000000020948 Boggi U, Palladino S, Massimetti G, Vistoli F, Caniglia F, De Lio N, Perrone V, Barbarello L, Belluomini M, Signori S, Amorese G, Mosca F (2015) Laparoscopic robot-assisted versus open total pancreatectomy: a case-matched study. Surg Endosc 29(6):1425–1432. https://doi.org/10.1007/s00464-014-3819-9 Zureikat AH, Nguyen T, Boone BA, Wijkstrom M, Hogg ME, Humar A, Zeh H (2015) Robotic total pancreatectomy with or without autologous islet cell transplantation: replication of an open technique through a minimal access approach. Surg Endosc 29(1):176–183. https://doi.org/10.1007/s00464-014-3656-x Giulianotti PC, Addeo P, Buchs NC, Bianco FM, Ayloo SM (2011) Early experience with robotic total pancreatectomy. Pancreas 40(2):311–313. https://doi.org/10.1097/MPA.0b013e3181f7e303 Malafa MP (2015) Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge. J Natl Compr Canc Netw 13(5):501–504. https://doi.org/10.6004/jnccn.2015.0068 Pedrazzoli S (2022) Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy. Surg Oncol 45:101858. https://doi.org/10.1016/j.suronc.2022.101858 Is There a Role for Laparoscopic and/or Robotic Techniques for Borderline Resectable Tumors? , bookTitle Multimodality Management of Borderline Resectable Pancreatic Cancer. Cham: Springer International Publishing; 2016. Kung JWC, Parks RW (2022) Vascular resections in minimally invasive surgery for pancreatic cancer. Laparosc Endosc Robotic Surg 5(1):3–9. https://doi.org/10.1016/j.lers.2021.09.003 Zureikat AH, Beane JD, Zenati MS, Al Abbas AI, Boone BA, Moser AJ, Bartlett DL, Hogg ME, Zeh HJ 3rd (2021) 500 minimally invasive robotic pancreatoduodenectomies: one decade of optimizing performance. Ann Surg 273(5):966–972. https://doi.org/10.1097/SLA.0000000000003550